During the past decade, Rothwell and Desborough Healthcare Group conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 4 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Rothwell and Desborough Healthcare Group" are "Cardiovascular Disease" (2 trials) and "Chronic Cough" (2 trials). Many other conditions were trialed in "Rothwell and Desborough Healthcare Group" in a lesser frequency.

Most popular intervention types in "Rothwell and Desborough Healthcare Group" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "bococizumab (PF-04950615)" (2 trials), "Gefapixant" (1 trials), "Gefapixant 15 mg BID" (1 trials) and "Gefapixant 45 mg BID" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rothwell and Desborough Healthcare Group" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Rothwell and Desborough Healthcare Group". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Rothwell and Desborough Healthcare Group, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Rothwell and Desborough Healthcare Group, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".